Breaking News

Has no content to show!

Pharmaceutical News

Aurobindo Pharma in talks to buy Shreya Life Sciences’s Russia business

Aurobindo Pharma Ltd is in talks to buy the Russia business of Mumbai-based Shreya Life Sciences Pvt. Ltd in a deal potentially valued between $80 million and $100 million, two people aware of the discussions said on condition of anonymity.


Investors file class action suit against Dr. Reddy’s in US court

Dr. Reddy’s Laboratories Ltd said on Monday that some investors had filed a class action lawsuit against the drug maker in the US District Court of New Jersey, alleging violation of US federal securities laws.Shares of the Hyderabad-based drug maker fell 2.8% on the announcement in intraday trading but recouped some of the loss later.


Pharma industry: After the wrong diagnosis, a worse prescription

Over the years, with more and more of the Indian pharmaceuticals industry subjected to different forms of price control, firms have focused more on the overseas business – from 43% of industry revenues in FY11, the domestic industry has been reduced to 34% in FY16.


Cipla profit rises 21% to Rs 409 cr in Q1 on cost controls, operational efficiency

Cipla on Friday posted 21 percent rise in net profit to Rs 409 crores on a year-on-year basis for the first quarter ended June 30 reigning in expenses and enhancing operational efficiency.


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners